Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung disease
References (20)
- et al.
Chest
(1996) - et al.
Life Sci
(1993) Life Sciences
(1993)- et al.
Am. Rev. Respir. Dis.
(1984) - et al.
Eur. Respir. J.
(1991) - et al.
N. Engl. J. Med.
(1993) Am.J. Respir. Crit.Care. Med.
(1995)- et al.
Eur. Respir. J.
(1995) - et al.
Am. J. Respir. Crit. Care Med.
(1994)
There are more references available in the full text version of this article.
Cited by (267)
Medicinal chemistry strategies to extend duration of action of inhaled drugs for intracellular targets
2022, Bioorganic and Medicinal Chemistry LettersDevelopment of an intracellular quantitative assay to measure compound binding kinetics
2022, Cell Chemical BiologyTiotropium in asthma: From bench to bedside
2019, Respiratory MedicineBinding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
2024, Journal of Pineal ResearchDesigning inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities
2024, Expert Opinion on Drug DiscoveryTherapeutic Targets and Precision Medicine in COPD: Inflammation, Ion Channels, Both, or Neither?
2023, International Journal of Molecular Sciences
Copyright © 1999 Published by Elsevier Inc.